Navigation Links
Angioplasty Scoring System Predicts Risk of Death
Date:8/27/2008

Clinicians use 7 simple variables to gauge in-hospital mortality after coronary intervention

WEDNESDAY, Aug. 27 (HealthDay News) -- A new scoring system for assessing patients' risk of in-hospital death after angioplasty has been confirmed to be effective, according to Mayo Clinic researchers who developed the system.

The Mayo Clinic Risk Score (MCRS) uses seven simple clinical and non-invasive variables to predict in-hospital death for percutaneous coronary intervention (PCI), the most widely performed heart revascularization process in the United States.

In 2005, doctors in the United States did more than 1.3 million PCIs, in which blocked arteries are cleared with a tiny balloon and propped open with a stent.

The Mayo researchers assessed the effectiveness of the MCRS by using it to review data on 309,351 patients who had PCI between 2004 and 2006. Their analysis indicated that the MCRS provided "excellent" predictions overall and in specific groups of patients categorized by age, gender, diabetes, renal failure, low ejection fraction and multi-vessel disease.

The researchers found that 97 percent of patients had a MCRS below 10, indicating low to intermediate risk. The MCRS initially slightly under-predicted rates of adverse events, but that problem was corrected after the system was recalibrated.

"Seven variables can be combined into a convenient risk scoring system before coronary angiography is performed to predict in-hospital mortality following PCI," the researchers wrote. "This model may be useful in providing patients with individualized, evidence-based estimates of procedural risk as part of the informed consent process before PCI."

The study was published Aug. 27 in the inaugural issue of the journal Circulation: Cardiovascular Interventions.

More information

The U.S. National Heart, Lung, and Blood Institute has more about angioplasty.



-- Robert Preidt



SOURCE: American Heart Association, news release, Aug. 27, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. 2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
2. On 30th Anniversary, Angioplasty Celebrated as Modern Medical Breakthrough in Stopping Heart Attack
3. Angioplasty Equals Bypass Surgery for Heart Patients: Study
4. Are women at greater risk from angioplasty?
5. Delayed angioplasty -- big bucks, no bang
6. Doing Angioplasty Long After Heart Attack Still Worth It, Analysis Shows
7. The Elderly Can Be Candidates for Angioplasty, Stenting
8. Comparison of anticoagulants for angioplasty show similar outcomes
9. Anticoagulant Drugs Had Similar Outcomes After Angioplasty
10. Angioplasty Proves Reasonable Alternative to Bypass Surgery
11. State Report Ranks LIJ as New Yorks Best Hospital for Angioplasty Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... management software and services, is proud to announce it has joined the National ... association representing the interests of chronically ill, disabled, and dying Americans of all ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the ... launch of a free, public-facing tool for analyzing the costs of various drug ... provide comparative information to patients, providers, insurers and pharmaceutical companies about the estimated ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a leading ... Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up ... association with efforts by the American College of Surgeons, U.S. Department of Defense, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of warmer weather ... those self-conscious about a double chin, this means more anxiety than elation. The cosmetic ... “For most people, a double chin is undesirable,” Dr. Goldman said, “but it seems ...
(Date:3/28/2017)... ... 28, 2017 , ... Calibration, qualification, and the appropriate level ... maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled ... these requirements are explained. The challenge is to determine how to put ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Neurim Pharmaceuticals ("Neurim") and Exeltis announced today ... for Neurim,s new Rx PedPRM in Spain . ... Neurim,s paediatric prolonged-release ... children with Autism Spectrum Disorders (ASD) and neurogenetic diseases. It is ... The collaboration with Exeltis will help increase the accessibility of ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... The U.S. could see significant economic benefits from the expanding ... Frontier Data, the legal cannabis market is projected to create 283,422 ... the United States , as well as the economic ... that drives growth in this sector. Medical cannabis is now legal ...
(Date:3/28/2017)... LONDON , March 28, 2017 The ... at a CAGR of 13.45% from 2016 to 2023 ... Description Cancer is a chronic disease ... emerging in the cancer diagnostics market. This report is ... tumor test. The market growth is propelled due to ...
Breaking Medicine Technology: